Totally agree. So many factors go into a bio succeeding and luck is a big one. Executing on the business plan even a couple of years later than planned can mean so much more dilution, which crimps shareholder returns in a big way.
- Forums
- Commodities
- Biotech Analysts $4M pa
Biotech Analysts $4M pa, page-17
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)